Lisanne N van Merendonk

6PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPharmaceutical delivery technologiesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 03, 2026
Clinical response to capecitabine in a DPYD*2A homozygous patient: Case report and therapeutic guidance.

Michiel A Damhof, Lisanne N van Merendonk, Marco B Polee

|May 16, 2023
Redispensing of expensive oral anticancer medicines: A practical application.

Kübra Akgöl, Lisanne N van Merendonk, Hannerieke J Barkman

|Mar 17, 2023
A new approach to drug intravenous compatibility research: the case of obstetric parenteral drugs.

A F Leeuwerik, L N van Merendonk, M A de Boer

|Feb 24, 2022
The potential for deprescribing in a palliative oncology patient population: a cross-sectional study.

Lisanne N van Merendonk, Bas J M Peters, Julia E Möhlmann

|Oct 07, 2021
Deprescribing in palliative patients with cancer: a concise review of tools and guidelines.

Lisanne N van Merendonk, Mirjam Crul

Pageof 1